Galena Biopharma, Inc. 4
4 · Galena Biopharma, Inc. · Filed Jan 24, 2017
Insider Transaction Report
Form 4
GALLIKER STEPHEN S
Director
Transactions
- Award
Common Stock
2017-01-20$1.98/sh+3,051$6,041→ 3,551 total
Footnotes (2)
- [F1]Effective January 1, 2017, 33% of the cash retainer payments to our Board will be paid in unrestricted shares of the Company's common stock, delivered from the 2016 Incentive Plan and priced on the first trading day of the quarter.
- [F2]Represents the closing stock price of the Company's stock on the first trading day of the quarter.